Should My Patient Accept a Kidney from a Hepatitis C Virus-Infected Donor?

被引：2
|
作者：
Pagan, Javier [1 ]
Ladino, Marco [1 ,2 ]
Roth, David [1 ]
机构：
[1] Univ Miami, Katz Family Div Nephrol & Hypertens, Miller Sch Med, 1120 NW 14th St,Room 813, Miami, FL 33136 USA
[2] Miami Vet Adm Healthcare Syst, Nephrol Sect, Miami, FL USA
来源：
KIDNEY360 | 2020年 / 1卷 / 02期
关键词：
Transplantation; Antiviral Agents; Hepatitis C virus; kidney transplantation; Tissue Donors; ACTING ANTIVIRAL THERAPY; TRANSPLANT RECIPIENTS; GENOTYPE; SOFOSBUVIR; EFFICACY; SAFETY;
D O I：
10.34067/KID.0001012019
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：127 / 129
页数：3
相关论文
共 50 条
  • [31] Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients
    Sherman, KE
    Shire, NJ
    Rouster, SD
    Peters, MG
    Koziel, MJ
    Chung, RT
    Horn, PS
    GASTROENTEROLOGY, 2005, 128 (02) : 313 - 327
  • [32] Impact of Willingness to Accept a Hepatitis C Viremic Donor Kidney on Access to Transplant
    Mckinney, Warren T.
    Schladt, David P.
    Israni, Ajay K.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 824 - 825
  • [33] Liver transplantation with hepatitis C virus-infected graft: Interaction between donor and recipient viral strains
    Fan, XF
    Lang, DM
    Xu, YJ
    Lyra, AC
    Yusim, K
    Everhart, JE
    Korber, BTM
    Perelson, AS
    Di Bisceglie, AM
    HEPATOLOGY, 2003, 38 (01) : 25 - 33
  • [34] Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus
    Crovatto, M
    Pozzato, G
    Zorat, F
    Pussini, E
    Nascimben, F
    Baracetti, S
    Grando, MG
    Mazzaro, C
    Reitano, M
    Modolo, ML
    Martelli, P
    Spada, A
    Santini, G
    HAEMATOLOGICA, 2000, 85 (04) : 356 - 361
  • [35] Hepatitis C virus in peripheral blood mononuclear cells from a chronically infected patient receiving liver graft from infected donor
    Radkowski, M
    Wang, LF
    Vargas, H
    Rakela, J
    Laskus, T
    TRANSPLANTATION, 1999, 67 (04) : 627 - 629
  • [36] Ultrastructural observations in hepatitis C virus-infected lymphoid cells
    Steffan, AM
    Marianneau, P
    Caussin-Schwemling, C
    Royer, C
    Schmitt, C
    Jaeck, D
    Wolf, P
    Gendrault, JL
    Stoll-Keller, F
    MICROBES AND INFECTION, 2001, 3 (03) : 193 - 202
  • [37] Executive functions in chronic hepatitis C virus-infected patients
    Peixoto, Bruno
    Lopez, Laudino
    Areias, Jorge
    Cerqueira, Rute
    Arias, Jorge L.
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 17 (01): : 53 - 60
  • [38] Prolonged seronegativity in a hepatitis C virus infected donor
    Beddard, RL
    Lawless, K
    Harrison, CR
    TRANSFUSION, 2005, 45 (03) : 92A - 92A
  • [39] Management of hepatitis C in human immunodeficiency virus-infected patients
    Bruno, R
    Puoti, M
    Sacchi, P
    Carosi, G
    Filice, G
    DIGESTIVE AND LIVER DISEASE, 2002, 34 (06) : 452 - 459
  • [40] Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients
    Mattar, Ehab H.
    Almehdar, Hussein A.
    AlJaddawi, Abdullah A.
    Abu Zeid, Isam ElDin M.
    Redwan, Elrashdy M.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
12345